Search results
Showing 91 to 105 of 199 results for biopsy
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (HTG228)
Evidence-based recommendations on endoscopic submucosal dissection (ESD) of oesophageal dysplasia and neoplasia. This involves inserting a long camera through the mouth into the oesophagus to view the area and removing the abnormal part with special instruments.
View recommendations for HTG228Show all sections
Sections for HTG228
multiparametric MRI is useful in identifying lesions before biopsy, and the combination of MRI with prostate biopsy leads...
multiparametric MRI is useful in identifying lesions before biopsy, and the combination of MRI with prostate biopsy leads...
Early value assessment (EVA) guidance on artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway.
High-intensity focused ultrasound for symptomatic breast fibroadenoma (HTG449)
Evidence-based recommendations on high-intensity focused ultrasound for symptomatic breast fibroadenoma in adults. This involves using high-frequency sound waves to heat up the tissues in the lump.
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography .
surgery, compared with excision with a 0.5 cm clinical margin, in preventing biopsy proven local recurrence at 5 years? This should be...
Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus (HTG346)
Evidence-based recommendations on endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus. This involves using radiofrequency (heat) energy to destroy the abnormal cells and to promote the growth of healthy squamous cells.
This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.
Focal therapy using high-intensity focused ultrasound for localised prostate cancer (HTG667)
Evidence-based recommendations on focal therapy using high-intensity focused ultrasound for localised prostate cancer. This involves using high-intensity focused ultrasound to heat up and destroy only the areas of the prostate with cancer (focal therapy). The aim is to destroy the cancer while reducing damage to healthy prostate tissue.
View recommendations for HTG667Show all sections
Prolaris gene expression assay for assessing long-term risk of prostate cancer progression (MIB65)
NICE has developed a medtech innovation briefing (MIB) on the Prolaris gene expression assay for assessing long-term risk of prostate cancer progression
SimpliCT laser-guided needle placement in interventional radiology (MIB98)
NICE has developed a medtech innovation briefing (MIB) on SimpliCT laser-guided needle placement in interventional radiology .
MammaTyper in vitro diagnostic test for determining breast cancer subtypes (MIB135)
NICE has developed a medtech innovation briefing (MIB) on the MammaTyper in vitro diagnostic test for determining breast cancer subtypes .
Balloon catheter insertion for Bartholin's cyst or abscess (HTG204)
Evidence-based recommendations on balloon catheter insertion for Bartholin's cyst or abscess. This involves making a passage from the cyst or abscess through which the gland can drain by inflating a small, specially designed balloon.
View recommendations for HTG204Show all sections
Sections for HTG204
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids (HTG590)
Evidence-based recommendations on hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids in adults. This involves cutting the fibroids into small pieces to remove them.
View recommendations for HTG590Show all sections